New Name and Positioning Reflects Broader Focus Within the Value-Based Care Environment
CHICAGO, IL (January 24, 2018) – To better reflect its expanded focus, Procured Health, the leading provider of data-driven analytics, evidence and expert guidance to help health systems cut costs and reduce unwarranted clinical variation, has changed its name to Lumere.
“We are pleased to announce this expanded focus and new name as the move toward value-based care accelerates,” said Hani Elias, JD, MPH, Chief Executive Officer of Lumere. “We formed Procured Health in 2012 to help hospitals and physicians make evidence-based, data-driven medical device selection and utilization decisions. We have since realized that the need for evidence-based medicine extends beyond device selection and that health systems are eager to support physicians in their quest to improve patient outcomes and performance. We have expanded our capabilities significantly to meet these needs and feel this new identity more accurately represents our expanded scope and mission.”
Lumere is backed by world-class healthcare investors including Heritage Group, FCA Ventures and F-Prime Capital Partners. The firm’s expanded focus includes added capabilities that address medication utilization and physician performance. The insights and recommendations are derived from a proprietary database that includes outcomes data and clinically-vetted benchmarks.
The company partners with over 60 health systems in more than 40 states and the United Kingdom. The goal is to ensure that care delivery choices are backed by data and guided by evidence, and drug and device costs are justified by clinical outcomes to make the best care decisions for every patient. This is achieved through the application of clinically focused information, analytics, technology and expertise.
“There is more data today than ever before to help doctors make decisions that improve outcomes and eliminate unnecessary costs,” said John Cherf, MD, MPH, MBA, Chief Medical Officer at Lumere. “It is our mission to leverage that data to effect change. We chose the name Lumere because it evokes an ideal state of enlightened healthcare where physicians can readily access unbiased, comprehensive insights to make cost-effective care delivery decisions.”
The most recent addition to Lumere’s solution suite was the launch of its web-based Pharmacy solutions that link a health system’s drug spend and utilization data to clinical evidence. In addition, the company has recently launched innovative professional services to support health systems seeking to provide dedicated performance improvement resources to physicians.
Aside from the name change, the company is making no other ownership or governance changes.
Lumere is at the forefront of clinical decision making for drugs and devices, offering evidence-based solutions and services for all providers that improve care and reduce cost across the patient journey. For more information, visit Lumere.com, find us on LinkedIn, follow @LumereHQ on Twitter and like us on Facebook.